Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	ADNP2 ZNF69 HIVEP3 ZNF750 ZNF777 HIC1 ZFAT HIVEP2 ZNF442 GLI1 ZNF433 ZNF124	7.17e-06	1412	38	12	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	ZNF69 HIVEP3 ZNF750 ZNF777 ZFAT ZNF581 HIVEP2 ZNF442 GLI1 ZNF433 ZNF124	5.81e-05	1459	38	11	GO:0000977
GeneOntologyBiologicalProcess	pulmonary artery morphogenesis	LRP2 JAG1	4.93e-05	6	38	2	GO:0061156
MousePheno	short snout	LRP2 HIC1 ADAMTS2 JAG1 DNMT3B	4.52e-06	136	26	5	MP:0000445
MousePheno	small snout	LRP2 HIC1 ADAMTS2 JAG1 DNMT3B	5.98e-06	144	26	5	MP:0030190
MousePheno	abnormal snout morphology	LRP2 HIC1 ADAMTS2 JAG1 DNMT3B	9.69e-05	257	26	5	MP:0000443
Domain	Znf_C2H2-like	ADNP2 ZNF69 HIVEP3 ZNF750 ZNF777 HIC1 ZFAT ZNF581 HIVEP2 ZNF442 GLI1 ZNF433 ZNF124	1.92e-09	796	37	13	IPR015880
Domain	Znf_C2H2	ADNP2 ZNF69 HIVEP3 ZNF750 ZNF777 HIC1 ZFAT ZNF581 HIVEP2 ZNF442 GLI1 ZNF433 ZNF124	2.19e-09	805	37	13	IPR007087
Domain	ZnF_C2H2	ADNP2 ZNF69 HIVEP3 ZNF750 ZNF777 HIC1 ZFAT ZNF581 HIVEP2 ZNF442 GLI1 ZNF433 ZNF124	2.30e-09	808	37	13	SM00355
Domain	ZINC_FINGER_C2H2_2	ADNP2 ZNF69 HIVEP3 ZNF777 HIC1 ZFAT ZNF581 HIVEP2 ZNF442 GLI1 ZNF433 ZNF124	1.70e-08	775	37	12	PS50157
Domain	ZINC_FINGER_C2H2_1	ADNP2 ZNF69 HIVEP3 ZNF777 HIC1 ZFAT ZNF581 HIVEP2 ZNF442 GLI1 ZNF433 ZNF124	1.75e-08	777	37	12	PS00028
Domain	-	ZNF69 HIVEP3 ZNF777 HIC1 ZFAT ZNF581 HIVEP2 ZNF442 GLI1 ZNF433 ZNF124	4.88e-08	679	37	11	3.30.160.60
Domain	zf-C2H2	ZNF69 HIVEP3 ZNF777 HIC1 ZFAT ZNF581 HIVEP2 ZNF442 GLI1 ZNF433 ZNF124	6.01e-08	693	37	11	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF69 HIVEP3 ZNF777 HIC1 ZFAT ZNF581 HIVEP2 ZNF442 GLI1 ZNF433 ZNF124	6.10e-08	694	37	11	IPR013087
Domain	Ribosomal_L10e	RPL10L RPL10	3.82e-06	2	37	2	IPR001197
Domain	Ribosomal_L10e_CS	RPL10L RPL10	3.82e-06	2	37	2	IPR018255
Domain	RIBOSOMAL_L10E	RPL10L RPL10	3.82e-06	2	37	2	PS01257
Domain	-	RPL10L RPL10	1.14e-05	3	37	2	3.90.1170.10
Domain	Ribosomal_L16	RPL10L RPL10	1.14e-05	3	37	2	PF00252
Domain	Ribosomal_L10e/L16	RPL10L RPL10	1.14e-05	3	37	2	IPR016180
Domain	EGF_Ca-bd_CS	LRP2 SCUBE1 JAG1 SLIT3	3.96e-05	97	37	4	IPR018097
Domain	EGF_CA	LRP2 SCUBE1 JAG1 SLIT3	4.29e-05	99	37	4	PS01187
Domain	EGF-type_Asp/Asn_hydroxyl_site	LRP2 SCUBE1 JAG1 SLIT3	5.60e-05	106	37	4	IPR000152
Domain	EGF_CA	LRP2 SCUBE1 JAG1 SLIT3	9.69e-05	122	37	4	SM00179
Domain	EGF-like_Ca-bd_dom	LRP2 SCUBE1 JAG1 SLIT3	1.03e-04	124	37	4	IPR001881
Domain	Growth_fac_rcpt_	LRP2 SCUBE1 JAG1 SLIT3	2.50e-04	156	37	4	IPR009030
Domain	EGF_CA	LRP2 SCUBE1 JAG1	6.54e-04	86	37	3	PF07645
Domain	KRAB	ZNF69 ZNF777 ZNF442 ZNF433 ZNF124	6.62e-04	358	37	5	PS50805
Domain	KRAB	ZNF69 ZNF777 ZNF442 ZNF433 ZNF124	6.62e-04	358	37	5	PF01352
Domain	KRAB	ZNF69 ZNF777 ZNF442 ZNF433 ZNF124	7.59e-04	369	37	5	SM00349
Domain	KRAB	ZNF69 ZNF777 ZNF442 ZNF433 ZNF124	7.68e-04	370	37	5	IPR001909
Domain	ASX_HYDROXYL	LRP2 SCUBE1 JAG1	1.01e-03	100	37	3	PS00010
Domain	EGF_3	LRP2 SCUBE1 JAG1 SLIT3	1.16e-03	235	37	4	PS50026
Domain	EGF	LRP2 SCUBE1 JAG1 SLIT3	1.16e-03	235	37	4	SM00181
Domain	cEGF	LRP2 SCUBE1	1.20e-03	26	37	2	IPR026823
Domain	cEGF	LRP2 SCUBE1	1.20e-03	26	37	2	PF12662
Domain	EGF-like_dom	LRP2 SCUBE1 JAG1 SLIT3	1.44e-03	249	37	4	IPR000742
Domain	EGF_1	LRP2 SCUBE1 JAG1 SLIT3	1.57e-03	255	37	4	PS00022
Domain	EGF-like_CS	LRP2 SCUBE1 JAG1 SLIT3	1.71e-03	261	37	4	IPR013032
Domain	EGF_2	LRP2 SCUBE1 JAG1 SLIT3	1.81e-03	265	37	4	PS01186
Domain	EGF	LRP2 JAG1 SLIT3	1.97e-03	126	37	3	PF00008
Domain	VWC	CHRDL1 JAG1	2.57e-03	38	37	2	SM00214
Domain	VWF_dom	CHRDL1 JAG1	3.13e-03	42	37	2	IPR001007
Domain	zf-C2H2_6	ZNF69 HIC1 ZNF442 ZNF433	3.34e-03	314	37	4	PF13912
Domain	EGF_extracell	LRP2 JAG1	6.29e-03	60	37	2	IPR013111
Domain	EGF_2	LRP2 JAG1	6.29e-03	60	37	2	PF07974
Domain	Cys-rich_flank_reg_C	SLIT3 AMIGO2	1.37e-02	90	37	2	IPR000483
Domain	LRRCT	SLIT3 AMIGO2	1.37e-02	90	37	2	SM00082
Domain	LRRNT	SLIT3 AMIGO2	1.61e-02	98	37	2	IPR000372
Domain	LRRNT	SLIT3 AMIGO2	1.61e-02	98	37	2	SM00013
Pubmed	Two genes encode factors with NF-kappa B- and H2TF1-like DNA-binding properties.	HIVEP3 HIVEP2	1.16e-06	2	38	2	2247438
Pubmed	Uncoupling of growth plate maturation and bone formation in mice lacking both Schnurri-2 and Schnurri-3.	HIVEP3 HIVEP2	1.16e-06	2	38	2	20404140
Pubmed	Myocardial Angiopoietin-1 Controls Atrial Chamber Morphogenesis by Spatiotemporal Degradation of Cardiac Jelly.	ADAMTS2 TIMP3 JAG1	2.40e-06	24	38	3	29791855
Pubmed	Dampening of death pathways by schnurri-2 is essential for T-cell development.	HIVEP3 HIVEP2	3.48e-06	3	38	2	21475200
Pubmed	ZEB2 controls kidney stromal progenitor differentiation and inhibits abnormal myofibroblast expansion and kidney fibrosis.	LRP2 GLI1 JAG1	5.30e-06	31	38	3	36445780
Pubmed	The role of ADAMTS-2, collagen type-1, TIMP-3 and papilin levels of uterosacral and cardinal ligaments in the etiopathogenesis of pelvic organ prolapse among women without stress urinary incontinence.	ADAMTS2 TIMP3	6.96e-06	4	38	2	30388611
Pubmed	Targeting skeletal endothelium to ameliorate bone loss.	HIVEP3 SLIT3	6.96e-06	4	38	2	29785024
Pubmed	HIC1 epigenetically represses CIITA transcription in B lymphocytes.	HIC1 DNMT3B	1.16e-05	5	38	2	27720955
Pubmed	Megalin mediates the influence of sonic hedgehog on oligodendrocyte precursor cell migration and proliferation during development.	LRP2 GLI1	2.43e-05	7	38	2	22354480
Pubmed	Differential regulation of gene expression in the digit forming area of the mouse limb bud by SHH and gremlin 1/FGF-mediated epithelial-mesenchymal signalling.	GLI1 JAG1	2.43e-05	7	38	2	16908629
Pubmed	PIBF1 regulates trophoblast syncytialization and promotes cardiovascular development.	ADAMTS2 TIMP3 JAG1	3.75e-05	59	38	3	38374152
Pubmed	Identification of disease-relevant modulators of the SHH pathway in the developing brain.	LRP2 GLI1	4.16e-05	9	38	2	34463328
Pubmed	Expression of the type IV collagenase system during mouse kidney development and tubule segmentation.	LRP2 TIMP3	4.16e-05	9	38	2	11675412
Pubmed	Endothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndrome.	TIMP3 JAG1	4.16e-05	9	38	2	23095891
Pubmed	Hnf4a deletion in the mouse kidney phenocopies Fanconi renotubular syndrome.	LRP2 JAG1	5.20e-05	10	38	2	30046000
Pubmed	Tbx5 inhibits hedgehog signaling in determination of digit identity.	GLI1 JAG1	5.20e-05	10	38	2	31373354
Pubmed	The Shh-independent activator function of the full-length Gli3 protein and its role in vertebrate limb digit patterning.	GLI1 JAG1	5.20e-05	10	38	2	17400206
Pubmed	Lgr5(+ve) stem/progenitor cells contribute to nephron formation during kidney development.	LRP2 JAG1	6.35e-05	11	38	2	22999937
Pubmed	Hedgehog signaling regulates sensory cell formation and auditory function in mice and humans.	GLI1 JAG1	9.00e-05	13	38	2	18632939
Pubmed	LRP2 is an auxiliary SHH receptor required to condition the forebrain ventral midline for inductive signals.	LRP2 GLI1	1.21e-04	15	38	2	22340494
Pubmed	Hoxd and Gli3 interactions modulate digit number in the amniote limb.	GLI1 JAG1	1.21e-04	15	38	2	17714700
Pubmed	Late gestational lung hypoplasia in a mouse model of the Smith-Lemli-Opitz syndrome.	LRP2 GLI1	1.38e-04	16	38	2	15005800
Pubmed	Conserved and Divergent Features of Human and Mouse Kidney Organogenesis.	LRP2 JAG1	1.56e-04	17	38	2	29449453
Pubmed	The role of floor plate contact in the elaboration of contralateral commissural projections within the embryonic mouse spinal cord.	GLI1 SLIT3	1.76e-04	18	38	2	16854408
Pubmed	LRP2 controls sonic hedgehog-dependent differentiation of cardiac progenitor cells during outflow tract formation.	LRP2 GLI1	1.76e-04	18	38	2	32901292
Pubmed	A High-Density Map for Navigating the Human Polycomb Complexome.	ADNP2 ZNF581 HIVEP2 FBXO5 RPL10	1.95e-04	495	38	5	27705803
Pubmed	Generation of Distal Renal Segments Involves a Unique Population of Aqp2 + Progenitor Cells.	LRP2 JAG1	1.96e-04	19	38	2	34667084
Pubmed	Disrupted Slit-Robo signalling results in membranous ventricular septum defects and bicuspid aortic valves.	JAG1 SLIT3	1.96e-04	19	38	2	25691540
Pubmed	Evolution of Cortical Neurogenesis in Amniotes Controlled by Robo Signaling Levels.	JAG1 SLIT3	2.18e-04	20	38	2	29961574
Pubmed	Suppressor of Fused restraint of Hedgehog activity level is critical for osteogenic proliferation and differentiation during calvarial bone development.	GLI1 JAG1	2.41e-04	21	38	2	28794157
Pubmed	Cooperation of BMP and IHH signaling in interdigital cell fate determination.	CHRDL1 GLI1	2.41e-04	21	38	2	29771958
Pubmed	Loss of Zeb2 in mesenchyme-derived nephrons causes primary glomerulocystic disease.	LRP2 JAG1	2.41e-04	21	38	2	27591083
Pubmed	Transduction of graded Hedgehog signaling by a combination of Gli2 and Gli3 activator functions in the developing spinal cord.	GLI1 JAG1	2.65e-04	22	38	2	15215207
Pubmed	DNA Methyltransferase 1 Controls Nephron Progenitor Cell Renewal and Differentiation.	JAG1 DNMT3B	2.65e-04	22	38	2	30518531
Pubmed	Patched 1 is a crucial determinant of asymmetry and digit number in the vertebrate limb.	GLI1 JAG1	2.90e-04	23	38	2	19783740
Pubmed	Dual mechanism underlying failure of neural tube closure in the Zic2 mutant mouse.	CHRDL1 GLI1	3.16e-04	24	38	2	36916392
Pubmed	GLI3 resides at the intersection of hedgehog and androgen action to promote male sex differentiation.	GLI1 JAG1	3.16e-04	24	38	2	32497091
Pubmed	The formation of the thumb requires direct modulation of Gli3 transcription by Hoxa13.	GLI1 JAG1	3.16e-04	24	38	2	31896583
Pubmed	Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.	ADNP2 ZNF777 GTF3C4	3.49e-04	125	38	3	32891193
Pubmed	LRP2 Acts as SHH Clearance Receptor to Protect the Retinal Margin from Mitogenic Stimuli.	LRP2 GLI1	3.72e-04	26	38	2	26439398
Pubmed	Type 1 fibroblast growth factor receptor in cranial neural crest cell-derived mesenchyme is required for palatogenesis.	GLI1 JAG1	3.72e-04	26	38	2	23754280
Pubmed	Notch2 regulates BMP signaling and epithelial morphogenesis in the ciliary body of the mouse eye.	CHRDL1 JAG1	4.01e-04	27	38	2	23676271
Pubmed	Genomic architecture of Shh-dependent cochlear morphogenesis.	GLI1 JAG1	4.32e-04	28	38	2	31488567
Pubmed	pRb-mediated control of epithelial cell proliferation and Indian hedgehog expression in mouse intestinal development.	GLI1 JAG1	4.96e-04	30	38	2	17257418
Pubmed	Molecular profiling of the vestibular lamina highlights a key role for Hedgehog signalling.	SCUBE1 GLI1	5.30e-04	31	38	2	36971701
Pubmed	ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.	ADNP2 GTF3C4 DNMT3B	5.94e-04	150	38	3	28242625
Pubmed	Lhx2 is a direct NF-κB target gene that promotes primary hair follicle placode down-growth.	SCUBE1 GLI1	6.01e-04	33	38	2	26952977
Pubmed	Negative regulation of Shh levels by Kras and Fgfr2 during hair follicle development.	GLI1 JAG1	6.38e-04	34	38	2	23123965
Pubmed	Disruption of mitochondrial complex III in cap mesenchyme but not in ureteric progenitors results in defective nephrogenesis associated with amino acid deficiency.	LRP2 JAG1	6.38e-04	34	38	2	35341793
Pubmed	DNA Damage Regulates Translation through β-TRCP Targeting of CReP.	HIVEP2 FBXO5	6.76e-04	35	38	2	26091241
Pubmed	Cubilin, a high affinity receptor for fibroblast growth factor 8, is required for cell survival in the developing vertebrate head.	LRP2 GLI1	7.56e-04	37	38	2	23592779
Pubmed	The developing mouse coronal suture at single-cell resolution.	GLI1 JAG1	7.56e-04	37	38	2	34376651
Pubmed	Isolation and Characterization of Fetal Leydig Progenitor Cells of Male Mice.	GLI1 JAG1	7.56e-04	37	38	2	26697723
Pubmed	TWIST1 interacts with β/δ-catenins during neural tube development and regulates fate transition in cranial neural crest cells.	LRP2 JAG1	8.40e-04	39	38	2	35781329
Pubmed	MTG8 interacts with LHX6 to specify cortical interneuron subtype identity.	GLI1 JAG1	8.40e-04	39	38	2	36064547
Pubmed	HNF1B controls proximal-intermediate nephron segment identity in vertebrates by regulating Notch signalling components and Irx1/2.	LRP2 JAG1	8.83e-04	40	38	2	23362348
Pubmed	Single-cell profiling of epigenetic modifiers identifies PRDM14 as an inducer of cell fate in the mammalian embryo.	KDM5A DNMT3B	1.07e-03	44	38	2	24183668
Interaction	LRP1B interactions	LRP2 CHRDL1 TIMP3 RPL10	1.95e-05	85	38	4	int:LRP1B
Cytoband	19p13.2	ZNF69 ZNF442 ZNF433	9.08e-04	229	38	3	19p13.2
Cytoband	Ensembl 112 genes in cytogenetic band chr5q35	ADAMTS2 PDLIM7 SLIT3	9.79e-04	235	38	3	chr5q35
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ADNP2 ZNF69 HIVEP3 ZNF777 HIC1 ZFAT ZNF581 HIVEP2 ZNF442 GLI1 ZNF433 ZNF124	2.31e-09	718	33	12	28
Coexpression	LI_CISPLATIN_RESISTANCE_DN	CHRDL1 JAG1 AMIGO2	1.49e-05	33	38	3	M10150
ToppCell	droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP2 CHRDL1 ADAMTS2 GLI1 SLIT3	5.28e-07	187	38	5	4e553721fa5598cb211f44e3226280b7e6885484
ToppCell	droplet-Pancreas-Exocrine-18m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP2 CHRDL1 ADAMTS2 GLI1 SLIT3	5.28e-07	187	38	5	d36e7fc6125e7a4310499365022d38f34b757a73
ToppCell	droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP2 CHRDL1 ADAMTS2 GLI1 SLIT3	5.28e-07	187	38	5	827eae63fabf6892a82ce7779b5f395958d3d628
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HIC1 ADAMTS2 TIMP3 JAG1 SLIT3	5.86e-07	191	38	5	7b0d42a877540dbb346a76a62403e0d5d3e07fa6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HIC1 ADAMTS2 TIMP3 JAG1 SLIT3	5.86e-07	191	38	5	cd854b9c426924fdc84bf7f411f6dea447143e79
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HIVEP3 CHRDL1 ADAMTS2 TIMP3 SLIT3	6.33e-07	194	38	5	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HIC1 ADAMTS2 TIMP3 PDLIM7 SLIT3	6.83e-07	197	38	5	4cf4e9553397cd8dee883dbec24f41bec41aff99
ToppCell	proximal-3-mesenchymal-Adventitial_Fibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CHRDL1 HIC1 ADAMTS2 TIMP3 SLIT3	7.36e-07	200	38	5	869d45b71efd395d050873db5fee2ed0443d5e6f
ToppCell	proximal-mesenchymal-Adventitial_Fibroblast\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CHRDL1 HIC1 ADAMTS2 TIMP3 SLIT3	7.36e-07	200	38	5	58c5870030192b337e7d883044948634fcd17d2c
ToppCell	proximal-mesenchymal-Adventitial_Fibroblast-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CHRDL1 HIC1 ADAMTS2 TIMP3 SLIT3	7.36e-07	200	38	5	05486d86868f6a93429226063cca270f00dd8714
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CHRDL1 HIC1 ADAMTS2 SLIT3	1.01e-05	159	38	4	a75ab494959575143cefdaec99e7aee3f318d559
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CHRDL1 HIC1 ADAMTS2 SLIT3	1.01e-05	159	38	4	cfb4a8c8aac34b1a857956d98382d487abcf5444
ToppCell	RV-13._Vascular_Smooth_Muscle\|RV / Chamber and Cluster_Paper	PDLIM7 RPL10 JAG1 SLIT3	1.06e-05	161	38	4	47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell	LPS-IL1RA-Unknown-Endothelial-Monocytes-Macrophages\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HIVEP2 RBM48 JAG1 AMIGO2	1.11e-05	163	38	4	6b11a3ada8725670d0489f404c8c2175ad3904e9
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHRDL1 ADAMTS2 RPL10 SLIT3	1.28e-05	169	38	4	8bfa2d3bb541d02f55d7c95b8fd156c8403befca
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHRDL1 ADAMTS2 RPL10 SLIT3	1.28e-05	169	38	4	bb43abad2c049b7f4d307737347290e01b3339a3
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHRDL1 ADAMTS2 RPL10 SLIT3	1.28e-05	169	38	4	5f18e3f40a5b1b167903f37516ec8181e889c7c5
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CHRDL1 HIC1 TIMP3 SLIT3	1.38e-05	172	38	4	1ef243bce63d841c25e4b74d029d1377f84bcc3d
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CHRDL1 HIC1 TIMP3 SLIT3	1.38e-05	172	38	4	ab1c81be29f93ca8920c6ab5ab92f497a9256d3f
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HIVEP3 HIC1 ADAMTS2 GLI1	1.61e-05	179	38	4	948c2a01ec7a626c68281e6e796a9f0527a88591
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ADAMTS2 PDLIM7 JAG1 SLIT3	1.75e-05	183	38	4	b4f29dd3994009bb5eb769d36d95886664e7f87d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TIMP3 PDLIM7 JAG1 SLIT3	1.75e-05	183	38	4	667717366cb181b8a04a347e64f0f5a4dfc6ee7f
ToppCell	droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZNF750 GRM5 RNF208 RPL10	1.79e-05	184	38	4	e0e5a553fb8c0947679634396d20c2ca8455b932
ToppCell	droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell-neuroendocrine\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZNF750 GRM5 RNF208 RPL10	1.79e-05	184	38	4	c3b848e1438a84b3fac8a4e40f3db478cc84d970
ToppCell	-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	CHRDL1 HIC1 TIMP3 SLIT3	1.95e-05	188	38	4	038f48e8daaeb72716e975d22a6b004a90654960
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CHRDL1 ADAMTS2 GLI1 SLIT3	2.08e-05	191	38	4	24dc77ee8de01b42559f92721655f4281b114e17
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ADAMTS2 PDLIM7 JAG1 SLIT3	2.08e-05	191	38	4	9431ffd6b758f756609d9057de2023596e22b5d4
ToppCell	ASK440-Mesenchymal-Fibroblast\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	CHRDL1 ADAMTS2 TIMP3 SLIT3	2.08e-05	191	38	4	387296b5377ef6839f0812e5b3529a10b5f7d530
ToppCell	ASK440-Mesenchymal\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	CHRDL1 ADAMTS2 TIMP3 SLIT3	2.08e-05	191	38	4	f12959eebb4167e1aa03de05d7711a702c58b3c9
ToppCell	5'-Adult-LymphNode-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHRDL1 HIC1 TIMP3 SLIT3	2.12e-05	192	38	4	9479e9859140ba98abfe88414de0b28fc2bf43b7
ToppCell	5'-Adult-LymphNode-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHRDL1 HIC1 TIMP3 SLIT3	2.12e-05	192	38	4	d7faa993f68e530ad55185505384ae155d36c222
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTS2 TIMP3 GLI1 SLIT3	2.12e-05	192	38	4	0e7e55505bd5454d7cf952a63fdcb46ec76f1973
ToppCell	facs-Lung-EPCAM-18m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHRDL1 HIC1 ADAMTS2 SLIT3	2.12e-05	192	38	4	5876ff75e273a48e7ad8236423fb41e4ae4c0a91
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTS2 TIMP3 GLI1 SLIT3	2.16e-05	193	38	4	025836c5c5a711e477c326559e618e47cae42d11
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CHRDL1 ADAMTS2 GLI1 SLIT3	2.16e-05	193	38	4	9d0b966d13cbce97beb43de6dc77f006c363a181
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS2 TIMP3 GLI1 SLIT3	2.16e-05	193	38	4	858a186804b36d45957238d3d3eed2768b961641
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CHRDL1 SCUBE1 PDLIM7 JAG1	2.16e-05	193	38	4	000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	TIMP3 PDLIM7 JAG1 SLIT3	2.16e-05	193	38	4	ba6eb29478d16589172f48f9992e5116328c81d6
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS2 TIMP3 GLI1 SLIT3	2.16e-05	193	38	4	7865e7ec0a288249540d4cba94ae01c93e1b617c
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HIVEP3 ADAMTS2 TIMP3 SLIT3	2.16e-05	193	38	4	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HIVEP3 ADAMTS2 TIMP3 SLIT3	2.16e-05	193	38	4	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TIMP3 PDLIM7 JAG1 SLIT3	2.21e-05	194	38	4	5099e6ad7c19e5f8b73449d904aaefd97f1b1959
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TIMP3 PDLIM7 JAG1 SLIT3	2.21e-05	194	38	4	71734ef7b34ab33b349595368176fa0e1175d4d0
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ADAMTS2 PDLIM7 JAG1 SLIT3	2.25e-05	195	38	4	43d372373367b71243c6ea958aedccde4478618f
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	HIC1 ADAMTS2 TIMP3 JAG1	2.30e-05	196	38	4	525d6c8a277364e624e7cc586275f8a891436b57
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHRDL1 TIMP3 GLI1 SLIT3	2.30e-05	196	38	4	e7bfd4fb400ae0c473131d0fa306c26be08a6d03
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHRDL1 TIMP3 GLI1 SLIT3	2.30e-05	196	38	4	82fad623212d986a7fca3496faf3f8c8f5b83a11
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 TIMP3 JAG1 SLIT3	2.30e-05	196	38	4	b8759e6231e0254797d6c30930407b79440c57bb
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHRDL1 TIMP3 GLI1 SLIT3	2.30e-05	196	38	4	85e5046f774537684e1443c0fc147d562b7068d0
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHRDL1 ADAMTS2 TIMP3 SLIT3	2.30e-05	196	38	4	cecf82cd5e0a3835d655f5e7478578674a63ce25
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 TIMP3 PDLIM7 SLIT3	2.30e-05	196	38	4	2b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHRDL1 TIMP3 RPL10 SLIT3	2.30e-05	196	38	4	988a3e0688e0a7ba69774497d3b130631bb26c50
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHRDL1 ADAMTS2 TIMP3 SLIT3	2.30e-05	196	38	4	9737a5f006d37b549f281e1863aca558e1e4dc99
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CHRDL1 ADAMTS2 TIMP3 SLIT3	2.30e-05	196	38	4	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHRDL1 ADAMTS2 TIMP3 SLIT3	2.34e-05	197	38	4	94a9603cbd3516fbcce871909693b88f20d41713
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes-Pericyte\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADAMTS2 TIMP3 JAG1 SLIT3	2.34e-05	197	38	4	452be45f4aac8459dd860493171f5f715368d663
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 TIMP3 PDLIM7 SLIT3	2.34e-05	197	38	4	80e153790cef37b743e22a7370ff5b3a6abf147d
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHRDL1 HIC1 ADAMTS2 TIMP3	2.34e-05	197	38	4	71786e9432e2d649f5d86f639abb25e7102deb67
ToppCell	droplet-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Scara5+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCUBE1 TIMP3 RPL10 SLIT3	2.39e-05	198	38	4	d4f74320ea6c1a7e568ee5bc48bb66cb45e1004d
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CHRDL1 ADAMTS2 TIMP3 SLIT3	2.39e-05	198	38	4	f1374f7a50244d59c766ac41f44c08c9117407d2
ToppCell	proximal-mesenchymal-Alveolar_Fibroblast\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CHRDL1 ADAMTS2 TIMP3 SLIT3	2.44e-05	199	38	4	7f4840ae6a888380feca722543e5e52783f3e35d
ToppCell	proximal-3-mesenchymal-Alveolar_Fibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CHRDL1 ADAMTS2 TIMP3 SLIT3	2.44e-05	199	38	4	301d02bbb37e6f1d24b6e865bc3fe3e91260eb30
ToppCell	(02)_MMP9/10+\|World / shred by cell type by condition	TIMP3 PDLIM7 JAG1 AMIGO2	2.44e-05	199	38	4	3f78eddeaa67d3b767aa38de765632166b09a4f0
ToppCell	(7)_Epithelial_cells-(7)_Epithelial-I_(AT1)\|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	SCUBE1 TIMP3 KDM5A AMIGO2	2.44e-05	199	38	4	5a002d49a8b84c158f7b4d7a3e78e6a937757bb7
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CHRDL1 ADAMTS2 TIMP3 SLIT3	2.44e-05	199	38	4	66a79732caf2f04c09b4d9832377aa01ca477677
ToppCell	ASK452-Mesenchymal-Fibroblast\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	CHRDL1 ADAMTS2 TIMP3 SLIT3	2.44e-05	199	38	4	4d0bf2a4bd97e5a3bfe4570a201cc21bb9c4c1f6
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHRDL1 HIC1 ADAMTS2 TIMP3	2.44e-05	199	38	4	9672230aa0bc6a7289050c955f5154ca183a5159
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHRDL1 HIC1 ADAMTS2 TIMP3	2.44e-05	199	38	4	e18abe678da293bd01fae55e2f9ab6fdd643d02d
ToppCell	proximal-mesenchymal-Alveolar_Fibroblast-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CHRDL1 ADAMTS2 TIMP3 SLIT3	2.44e-05	199	38	4	9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1
ToppCell	343B-Fibroblasts-Fibroblast-G\|343B / Donor, Lineage, Cell class and subclass (all cells)	CHRDL1 ADAMTS2 TIMP3 SLIT3	2.44e-05	199	38	4	f4b6c095cbe7a38b310adc49be4069e4d56e6a66
ToppCell	343B-Fibroblasts-Fibroblast-G-\|343B / Donor, Lineage, Cell class and subclass (all cells)	CHRDL1 ADAMTS2 TIMP3 SLIT3	2.44e-05	199	38	4	9c6d1c328bfbb6547f4c7bb2a784576a56bd72af
ToppCell	ASK452-Mesenchymal\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	CHRDL1 ADAMTS2 TIMP3 SLIT3	2.44e-05	199	38	4	93e85e3731a9ece9aee3eb82c5dfdad331ee62d6
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.4.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHRDL1 PDLIM7 GLI1 SLIT3	2.44e-05	199	38	4	66b4ff23b2e83fb7e6a37fdafdef315cfa33d327
ToppCell	proximal-3-mesenchymal\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CHRDL1 TIMP3 PDLIM7 SLIT3	2.48e-05	200	38	4	94250991f78ea56810412d00a4bb645eb975478c
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHRDL1 ADAMTS2 TIMP3 SLIT3	2.48e-05	200	38	4	933b5b400e48a511ba0a056be1d33d3610b5f10d
ToppCell	cellseq2-Mesenchymal-Myocytic-Myocytic_2-VSMC\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TIMP3 PDLIM7 JAG1 SLIT3	2.48e-05	200	38	4	fc802dd73f048881d9ddafd1b79ab3ca654510e2
ToppCell	cellseq2-Mesenchymal-Myocytic-Myocytic_2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TIMP3 PDLIM7 JAG1 SLIT3	2.48e-05	200	38	4	cffddb39960cd611428397c1ec4023192e8af5a7
ToppCell	Skin-Fibroblasts\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	CHRDL1 ADAMTS2 TIMP3 SLIT3	2.48e-05	200	38	4	f777eadf571a1a6d246da87346a9cb9d511c2e81
ToppCell	Bronchial-10x5prime-Stromal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CHRDL1 ADAMTS2 TIMP3 SLIT3	2.48e-05	200	38	4	5ea12e17f50fefbf5534e487af3392b2fa2d13ad
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CHRDL1 ADAMTS2 TIMP3 SLIT3	2.48e-05	200	38	4	6316c288022719b9e6c4332c5cb9041e1188d0e8
ToppCell	cellseq2-Mesenchymal-Myocytic\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TIMP3 PDLIM7 JAG1 SLIT3	2.48e-05	200	38	4	e60aebd20be8012fa2febf6585ed34ebd64ec9b3
ToppCell	Tracheal-10x5prime-Stromal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CHRDL1 ADAMTS2 TIMP3 SLIT3	2.48e-05	200	38	4	920e6036c0a9c0089d0d898673daf9dd9d7279fc
ToppCell	distal-3-mesenchymal-Airway_Smooth_Muscle\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PDLIM7 RPL10 JAG1 SLIT3	2.48e-05	200	38	4	4072cfb3047954f507289587b4bfaf1526936992
ToppCell	proximal-mesenchymal\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CHRDL1 TIMP3 PDLIM7 SLIT3	2.48e-05	200	38	4	29f3a5c85404c6537d6405d599ebae281e0d4d4f
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHRDL1 ADAMTS2 TIMP3 SLIT3	2.48e-05	200	38	4	10f0c20ba7c71d9e2e177597f85b41cb40f0d878
ToppCell	droplet-Fat-Mat-18m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHRDL1 ZNF777 HELQ	1.49e-04	121	38	3	e82c9e10b98c8d7ad828cf8ac19a2342014be2ba
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ADAMTS2 WFDC9 RPL10	2.02e-04	134	38	3	cb676d5bbc468bd3ce1b6712d41c986ee9221ac5
ToppCell	LPS-antiTNF-Hematopoietic_Meg-Ery-Mes-Epi-like\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHRDL1 SCUBE1 GRM5	2.11e-04	136	38	3	a2063abe2d7c3277bfbe1514c8c66363cf04b248
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Cdh13\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ADAMTS2 RPL10 SLIT3	2.11e-04	136	38	3	1f3000d5f105c87c80f8ae1dd2264bcd7f757a9c
ToppCell	LPS-antiTNF-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHRDL1 SCUBE1 GRM5	2.16e-04	137	38	3	8e2fa2ef8becace96a68bb85c002329110902fbb
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	HIC1 ZFAT KDM5A	2.39e-04	142	38	3	671ba8869db7a6dc69fd1caf0e561f15a312b170
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	HIC1 ZFAT KDM5A	2.39e-04	142	38	3	3557084150670fd2e2634fc674f228ab85181b59
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Alcam_(Alcam)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	HIC1 ZFAT KDM5A	2.39e-04	142	38	3	6a656d28c9f5dfb03a3a2d908cf2edbe0a5b1206
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Alcam_(Alcam)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	HIC1 ZFAT KDM5A	2.39e-04	142	38	3	a3d1f4b570b75402171e38c5a7c88e2896520c8f
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	HIC1 ADAMTS2 SLIT3	2.50e-04	144	38	3	1c001a5a3bbe4ecbce8305f8b260e933033550dd
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TIMP3 JAG1 SLIT3	2.92e-04	152	38	3	0cb5f4dfae04e3f4eba502bbf229007d5fa3884d
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TIMP3 JAG1 SLIT3	2.92e-04	152	38	3	ba89ffb5a8bb33c188f854f54b39123b6d73496a
ToppCell	NS-critical-d_0-4-Lymphoid-NKT\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SCUBE1 FBXO5 RPL10	3.04e-04	154	38	3	08ffa4b6f4a1c3de037acf9d30bd14c195738ad9
ToppCell	facs-Marrow-KLS-18m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIC1 SCUBE1 ADAMTS2	3.04e-04	154	38	3	37765512dfae557b9f6eb30a29463b93682a4404
ToppCell	PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	LRP2 CHRDL1 AMIGO2	3.16e-04	156	38	3	605d95a900e1443d3f6aae163ef2e893d3293203
Drug	5-aza-2'-deoxycytidine	HIVEP3 HIC1 GRM5 TIMP3 GLI1 JAG1 SLIT3 DNMT3B	8.46e-06	638	38	8	CID000016886
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	ADNP2 LRP2 HIVEP3 KDM5A ZNF124	1.58e-05	191	38	5	4279_DN
Drug	Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A	USP34 TIMP3 KDM5A RPL10 JAG1	1.58e-05	191	38	5	3605_DN
Drug	Ethamsylate [2624-44-4]; Down 200; 15.2uM; MCF7; HT_HG-U133A	RPL10L LRP2 ZNF442 TIMP3 KDM5A	1.75e-05	195	38	5	4399_DN
Drug	Buflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A	RPL10L LRP2 USP34 KDM5A PDLIM7	1.79e-05	196	38	5	4840_DN
Drug	Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Up 200; 7.8uM; PC3; HT_HG-U133A	RPL10L LRP2 CLDN17 RPL10 AMIGO2	1.83e-05	197	38	5	6708_UP
Drug	Prednicarbate [73771-04-7]; Down 200; 8.2uM; MCF7; HT_HG-U133A	RPL10L LRP2 HIVEP2 ZNF442 PDLIM7	1.88e-05	198	38	5	3542_DN
Drug	Neostigmine bromide [114-80-7]; Up 200; 13.2uM; HL60; HT_HG-U133A	RPL10L LRP2 PDLIM7 CLDN17 RPL10	1.88e-05	198	38	5	2432_UP
Drug	Telenzepine dihydrochloride [147416-96-4]; Up 200; 9uM; HL60; HT_HG-U133A	RPL10L HHLA1 RPL10 JAG1 AMIGO2	1.93e-05	199	38	5	2388_UP
Drug	AC1L2UHE	PDCD2 GLI1 RPL10	1.06e-04	55	38	3	CID000128814
Drug	penicillanic acid	PDCD2 RPL10	1.48e-04	11	38	2	CID000006891
Drug	acetylspiramycin	CHRDL1 PDCD2	1.77e-04	12	38	2	CID005282173
Drug	Mitoxantrone dihydrochloride [70476-82-3]; Down 200; 7.8uM; MCF7; HT_HG-U133A	RBM48 FBXO5 RPL10 AMIGO2	2.36e-04	182	38	4	5354_DN
Drug	AC1L9MW5	CHRDL1 RPL10	2.44e-04	14	38	2	CID000449237
Drug	Phenacetin [62-44-2]; Up 200; 22.4uM; MCF7; HT_HG-U133A	LRP2 USP34 KDM5A JAG1	2.72e-04	189	38	4	2832_UP
Drug	F0447-0125; Up 200; 10uM; PC3; HT_HG-U133A	USP34 RBM48 ZNF442 PDLIM7	2.78e-04	190	38	4	6429_UP
Drug	Dienestrol [84-17-3]; Up 200; 15uM; MCF7; HT_HG-U133A	USP34 ZNF750 ZNF442 PDLIM7	2.83e-04	191	38	4	3448_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A	PDLIM7 GLI1 JAG1 AMIGO2	2.89e-04	192	38	4	2450_UP
Drug	deferoxamine mesylate salt; Up 200; 100uM; MCF7; HG-U133A	HIVEP2 ADAMTS2 TIMP3 KDM5A	2.89e-04	192	38	4	485_UP
Drug	Testosterone propionate [57-85-2]; Up 200; 11.6uM; PC3; HT_HG-U133A	LRP2 PDLIM7 RPL10 JAG1	2.95e-04	193	38	4	4676_UP
Drug	Azathymine, 6 [932-53-6]; Up 200; 31.4uM; MCF7; HT_HG-U133A	RPL10L ZNF750 PDLIM7 JAG1	3.01e-04	194	38	4	2827_UP
Drug	Propofol [2078-54-8]; Down 200; 22.4uM; PC3; HT_HG-U133A	HIVEP3 CHRDL1 PDLIM7 DNMT3B	3.07e-04	195	38	4	6707_DN
Drug	Netilmicin sulfate [56931-57-2]; Down 200; 2.8uM; MCF7; HT_HG-U133A	RBM48 KDM5A PDLIM7 RPL10	3.13e-04	196	38	4	3524_DN
Drug	2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A	USP34 ZNF442 KDM5A JAG1	3.13e-04	196	38	4	5574_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A	HIVEP3 SLIT3 AMIGO2 DNMT3B	3.13e-04	196	38	4	2035_UP
Drug	Triamterene [396-01-0]; Down 200; 15.8uM; HL60; HT_HG-U133A	HIVEP2 RBM48 AMIGO2 DNMT3B	3.13e-04	196	38	4	1861_DN
Drug	Dyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A	LRP2 USP34 RBM48 PDLIM7	3.13e-04	196	38	4	7423_UP
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A	LRP2 HIVEP3 TIMP3 HHLA1	3.13e-04	196	38	4	6053_UP
Drug	Fluoxetine hydrochloride [59333-67-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A	LRP2 RBM48 KDM5A PDLIM7	3.13e-04	196	38	4	3314_UP
Drug	Trimetazidine dihydrochloride [13171-25-0]; Down 200; 11.8uM; MCF7; HT_HG-U133A	RBM48 KDM5A PDLIM7 JAG1	3.13e-04	196	38	4	2876_DN
Drug	Moxisylyte hydrochoride [964-52-3]; Up 200; 12.6uM; MCF7; HT_HG-U133A	ZNF442 TIMP3 PDLIM7 JAG1	3.13e-04	196	38	4	7015_UP
Drug	Terconazole [67915-31-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A	RPL10L HIVEP3 ZNF442 KDM5A	3.13e-04	196	38	4	4407_DN
Drug	Vancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; MCF7; HT_HG-U133A	LRP2 USP34 ZNF442 JAG1	3.19e-04	197	38	4	2858_UP
Drug	Prochlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A	HIVEP3 TIMP3 KDM5A RPL10	3.19e-04	197	38	4	2641_UP
Drug	Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A	LRP2 RBM48 ZNF442 JAG1	3.19e-04	197	38	4	1485_DN
Drug	Aminohippuric acid [61-78-9]; Down 200; 20.6uM; MCF7; HT_HG-U133A	HIVEP3 HIVEP2 PDLIM7 RPL10	3.19e-04	197	38	4	6453_DN
Drug	Prednisone [53-03-2]; Down 200; 11.2uM; PC3; HT_HG-U133A	HIVEP3 CHRDL1 PDLIM7 RPL10	3.19e-04	197	38	4	4577_DN
Drug	Tomatidine [77-59-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A	TIMP3 PDLIM7 CLDN17 SLIT3	3.19e-04	197	38	4	2746_UP
Drug	Benfotiamine [22457-89-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A	RPL10L HIVEP2 ZNF442 TIMP3	3.19e-04	197	38	4	3931_DN
Drug	Telenzepine dihydrochloride [147416-96-4]; Up 200; 9uM; MCF7; HT_HG-U133A	USP34 RBM48 KDM5A PDLIM7	3.19e-04	197	38	4	7419_UP
Drug	Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A	RPL10L TIMP3 PDLIM7 CLDN17	3.19e-04	197	38	4	4690_UP
Drug	MK-886; Down 200; 1uM; MCF7; HG-U133A	HIVEP2 TIMP3 HHLA1 SLIT3	3.19e-04	197	38	4	601_DN
Drug	Bumetanide [28395-03-1]; Up 200; 11uM; MCF7; HT_HG-U133A	RBM48 FBXO5 KDM5A RPL10	3.19e-04	197	38	4	7440_UP
Drug	Acetohexamide [968-81-0]; Up 200; 12.4uM; MCF7; HT_HG-U133A	USP34 FBXO5 PDLIM7 RPL10	3.19e-04	197	38	4	1707_UP
Drug	Saquinavir mesylate [149845-06-7]; Up 200; 5.2uM; HL60; HT_HG-U133A	LRP2 HHLA1 CLDN17 JAG1	3.25e-04	198	38	4	6127_UP
Drug	Atropine-N-oxide hydrochloride [4574-60-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A	LRP2 HIVEP3 TIMP3 CLDN17	3.25e-04	198	38	4	6812_UP
Drug	Isoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A	LRP2 USP34 ZNF442 TIMP3	3.25e-04	198	38	4	4789_UP
Drug	Brompheniramine maleate [980-71-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A	RPL10L HIVEP3 HIVEP2 RPL10	3.25e-04	198	38	4	4131_DN
Drug	Chlorogenic acid [327-97-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A	USP34 RBM48 PDLIM7 ZNF124	3.25e-04	198	38	4	3282_DN
Drug	Harmalol hydrochloride dihydrate [6028-07-5]; Down 200; 14.6uM; MCF7; HT_HG-U133A	LRP2 KDM5A PDLIM7 JAG1	3.25e-04	198	38	4	5495_DN
Drug	Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A	RPL10L USP34 ZNF442 JAG1	3.25e-04	198	38	4	2845_UP
Drug	Racecadotril [81110-73-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A	RPL10L HIVEP3 PDLIM7 RPL10	3.25e-04	198	38	4	6231_UP
Drug	Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A	USP34 KDM5A PDLIM7 RPL10	3.25e-04	198	38	4	2251_DN
Drug	Methacholine chloride [62-51-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A	PDLIM7 CLDN17 RPL10 JAG1	3.25e-04	198	38	4	6248_UP
Drug	Cefotetan [69712-56-7]; Down 200; 7uM; HL60; HT_HG-U133A	USP34 HIVEP2 PDLIM7 DNMT3B	3.31e-04	199	38	4	1319_DN
Drug	Flurbiprofen [5104-49-4]; Down 200; 16.4uM; MCF7; HT_HG-U133A	USP34 ZNF750 KDM5A PDLIM7	3.31e-04	199	38	4	5634_DN
Drug	Cyclacillin [3485-14-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A	TIMP3 KDM5A CLDN17 GLI1	3.31e-04	199	38	4	3882_UP
Drug	Buflomedil hydrochloride [35543-24-9]; Up 200; 11.6uM; MCF7; HT_HG-U133A	RPL10L LRP2 HHLA1 PDLIM7	3.31e-04	199	38	4	3274_UP
Drug	Piroxicam [36322-90-4]; Down 200; 12uM; MCF7; HT_HG-U133A	RPL10L HIVEP3 USP34 RPL10	3.31e-04	199	38	4	2252_DN
Drug	Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; MCF7; HT_HG-U133A	RPL10L ZNF750 KDM5A CLDN17	3.31e-04	199	38	4	4691_UP
Drug	Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	HIVEP3 USP34 PDCD2 RPL10	3.31e-04	199	38	4	4803_DN
Drug	Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; PC3; HT_HG-U133A	USP34 HIVEP2 RBM48 PDLIM7	3.38e-04	200	38	4	6333_DN
Drug	Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A	RPL10L LRP2 HIVEP3 USP34	3.38e-04	200	38	4	4824_DN
Drug	Flucytosine [2022-85-7]; Up 200; 31uM; MCF7; HT_HG-U133A	RPL10L LRP2 ZNF750 JAG1	3.38e-04	200	38	4	6450_UP
Drug	Ino-Hcy	HIC1 GRM5 ADAMTS2	3.59e-04	83	38	3	CID000193585
Drug	2,3-difluorobenzyl alcohol	GRM5 ADAMTS2	3.63e-04	17	38	2	CID000447153
Disease	T-cell acute lymphoblastic leukemia (implicated_via_orthology)	RPL10L RPL10	4.59e-06	3	37	2	DOID:5603 (implicated_via_orthology)
Disease	autistic disorder (implicated_via_orthology)	RPL10L RPL10	9.17e-06	4	37	2	DOID:12849 (implicated_via_orthology)
Disease	spondyloepiphyseal dysplasia congenita (implicated_via_orthology)	RPL10L RPL10	2.29e-05	6	37	2	DOID:14789 (implicated_via_orthology)
Disease	syndromic X-linked intellectual disability Najm type (implicated_via_orthology)	RPL10L RPL10	3.20e-05	7	37	2	DOID:0060807 (implicated_via_orthology)
Disease	autoimmune thyroiditis (is_implicated_in)	LRP2 ZFAT	1.00e-04	12	37	2	DOID:7188 (is_implicated_in)
Disease	juvenile polyposis syndrome (implicated_via_orthology)	HIVEP3 HIVEP2	1.18e-04	13	37	2	DOID:0050787 (implicated_via_orthology)
Disease	pulse pressure measurement	HIVEP3 USP34 HIC1 ZFAT KDM5A JAG1 SLIT3 DNMT3B	2.73e-04	1392	37	8	EFO_0005763
Disease	treatment resistant depression, response to antidepressant	HIVEP3 SLIT3	3.16e-04	21	37	2	EFO_0009854, GO_0036276
Disease	Age related macular degeneration	HIC1 TIMP3	6.51e-04	30	37	2	C0242383
Disease	Schizophrenia	ADNP2 LRP2 GRM5 JAG1 SLIT3 DNMT3B	7.43e-04	883	37	6	C0036341
Disease	Diaphragmatic Hernia	LRP2 SLIT3	1.22e-03	41	37	2	C0019284
Disease	endometriosis, unipolar depression	HIVEP2 GRM5	1.34e-03	43	37	2	EFO_0001065, EFO_0003761
Disease	multiple sclerosis (is_marker_for)	GLI1 JAG1	1.73e-03	49	37	2	DOID:2377 (is_marker_for)
Disease	Malignant neoplasm of breast	HIC1 HELQ PDLIM7 GLI1 JAG1 DNMT3B	2.03e-03	1074	37	6	C0006142
Disease	Premature atrial contractions	ZNF69 ZNF433	2.18e-03	55	37	2	HP_0006699
Disease	Alzheimer's disease (implicated_via_orthology)	HIVEP3 HIVEP2	2.34e-03	57	37	2	DOID:10652 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
DYCPAPKRLKTNCYN	DNMT3B	391	Q9UBC3
YLYLTPCPCKCKTKR	AMIGO2	416	Q86SJ2
LSRYCSIPGYNKLCC	ADAMTS2	1076	O95450
PSGKKVRYRTKPYCC	ADNP2	61	Q6IQ32
KPYCCGLCKYSTKVL	ADNP2	71	Q6IQ32
CCCNRKKQGYRYPVP	CLDN17	186	P56750
PYSCELPLCYFSSKC	RBM48	196	Q5RL73
CTFCLIAKPKQIYCY	GRM5	631	P41594
PYRCASCDKSYKDPA	HIC1	506	Q14526
LGPKTCSRCHKAYYC	PDCD2	141	Q16342
PYVCKLPGCTKRYTD	GLI1	361	P08151
LPKCKCPSGYTGKYC	LRP2	4396	P98164
PCYDVRYAPSCAKCK	PDLIM7	331	Q9NR12
LCPCPMQKKCLRYRY	KDM5A	706	P29375
ECKKIHCPNRYPCKY	CHRDL1	296	Q9BU40
KACIRCNSPAKYDCY	FBXO5	376	Q9UKT4
PNYSCLVFCPSKKNC	HELQ	576	Q8TDG4
QNTPKSYKCLCKPGY	SCUBE1	51	Q8IWY4
SCKNLIASYYCDCLP	JAG1	426	P78504
YCKNKPYPKSRFCRG	RPL10L	11	Q96L21
KTVDPAKFPTRYCYC	HHLA1	126	C9JL84
YCKNKPYPKSRFCRG	RPL10	11	P27635
CWVQPPYKYCEKRCT	WFDC9	41	Q8NEX5
CACPYSYKGKDCTVP	SLIT3	941	O75094
KPFKYKCFQCPFTCN	ZNF750	21	Q32MQ0
EKPYKCPQCSYASAI	ZFAT	296	Q9P243
ESCPKYKFISCPTCR	RNF208	176	Q9H0X6
KYICQYCSRPCAKPS	HIVEP3	191	Q5T1R4
CVPLYHPYQKCSCSL	GTF3C4	376	Q9UKN8
PYPCKQCGKAFRYAS	ZNF124	261	Q15973
PYECKQCCKAFPIYS	ZNF442	236	Q9H7R0
TYVKCPAPCQRTYVK	XP32	66	Q5T750
RPYKCKLCGKGFYCP	ZNF69	476	Q9UC07
ECKAYNPRPFCKTYT	USP34	1951	Q70CQ2
PGQKKCYSCPVCSRV	ZNF581	81	Q9P0T4
YPCTHCAKCFRYKQS	ZNF777	806	Q9ULD5
PGKYICPYCSRACAK	HIVEP2	186	P31629
CPYCSRACAKPSVLK	HIVEP2	191	P31629
PYKCKYCKKPFNCLS	ZNF433	141	Q8N7K0
EKPKYRCPACRVPYC	ZNHIT3	16	Q15649
LGCNCKIKSCYYLPC	TIMP3	141	P35625